Early intermittent low-dose sclerostin antibody treatment promotes surface bone formation and reduces bone loss, but also decreases osteocyte apoptosis and mechanotransduction in ovariectomized rats: a pilot study

SSRN Electronic Journal 2026 Preprint Open access

Read full text
Authors: Syeda Masooma Naqvi, Wahaaj Ali, Hollie Allison, Laura O'Sullivan, Gill Holdsworth, Juan Alberto Panadero-Perez, Jessica Schiavi, Laoise M. McNamara
DOI: 10.2139/ssrn.6021247
Cited by: 0

Fields of Study & Subjects

Bone health and osteoporosis research Bone Metabolism and Diseases Alkaline Phosphatase Research Studies

Publication details

Journal / source
SSRN Electronic Journal
Publication date
1 January 2026
Document type
Preprint